Furthermore, Grenald found that inhibition of S1PR1 could reduce cancer-induced bone pain (CIBP) and promote the expression of IL-10 in lumbar spinal cord, suggesting that S1PR1 is involved in the regulation of CIBP and neuroinflammation [36]. Here, IL10 is linked to cancer.